Physician profile
Thomas Mark Suszynski
NPI 1013336155
$6,621.18
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $269 · 2021: $1,652 · 2022: $90.24 · 2023: $252 · 2024: $4,172 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,418 · Travel and Lodging: $2,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,417.82 |
| Travel and Lodging | $2,192.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $4,178.80 | 2021-2024 | Aptus |
| Medtronic, INC. | $1,080.00 | 2021 | |
| Allergan, INC. | $285.42 | 2020-2021 | |
| Stryker Corporation | $270.71 | 2020-2023 | Variax |
| Axogen | $248.45 | 2021-2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Foundation Medical, LLC | $219.59 | 2023-2025 | |
| Abbvie INC. | $149.12 | 2024-2025 | |
| Trimed, INC. | $71.13 | 2022 | |
| Depuy Synthes Sales INC. | $52.81 | 2021 | |
| Mentor Worldwide LLC | $32.26 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Checkpoint Surgical, INC | $19.11 | 2022 | |
| Endo Pharmaceuticals INC. | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Suszynski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.